HeartflowvsMerck & Company

HTFL and MRK stock compared: price, dividend, valuation and results, from SEC filings.

HTFL

Heartflow, Inc.

$48.56

Value $4.2B

+0.21%
HTFL's page

MRK

Merck & Company, Inc.

$148.20

Value $366B

+0.26%
MRK's page

Heartflow (HTFL) has a market value of $4.2B and Merck & Company (MRK) $366B. Over the last year, with dividends, HTFL moved +73.6% and MRK +64.1%. Dividend yield: HTFL none, MRK 2.29%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    HTFL$4.2B

    MRK$366B

    MRK is 88 times HTFL

  • Revenue, 12 months

    HTFL$239M

    MRK$67.4B

    MRK is 282 times HTFL

  • Net income, 12 months

    HTFL-$79M

    MRK$2.5B

  • Operating margin

    HTFL-33.1%

    MRK–

  • ROIC

    HTFL-22.2%

    MRK3.9%

    26.1 points apart

  • P/E

    HTFL–

    MRK149.4

  • Dividend yield

    HTFL0.0%

    MRK2.3%

    2.3 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

HTFL+73.5%

MRK+64.1%

100150200DecFebAprJunAugOct
Returns by period
PeriodHTFLWith dividendsMRKWith dividends
1 year since November 14, 2025+73.6%Price +73.6%+64.1%Price +59.4%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

HTFLHeartflowMRKMerck & Company

Valuation

HTFLMRK
Valuation
Price$48.56$148.20
Market value$4.2B$366B
Enterprise value (EV)$3.9B$411B
P/E–149.4
P/E, 5-year median–14.8
P/B14.78.2
EV/EBIT–86.2
Free cash flow yield–4.0%

Results and growth

HTFLMRK
Results and growth
Revenue, 12 months$239M$67.4B
Net income, 12 months-$79M$2.5B
Free cash flow, 12 months-$56M$14.7B
Earnings per share, 12 months$0.67$0.98
Revenue growth, year on year39.9%1.3%
Revenue growth a year, past+42.1%over 2 years+9.4%over 5 years
EPS growth a year, past–+21.2%over 5 years

Margins and returns on capital

HTFLMRK
Margins and returns on capital
Gross margin81.9%71.8%
Operating margin-33.1%–
Net margin-33.1%3.6%
ROIC-22.2%3.9%
ROE-28.2%5.2%

Balance sheet

HTFLMRK
Balance sheet
Cash$253M$9.7B
Total debt$26M$53.8B
Net debt / EBITDA–5.7
Interest cover-4,937.5×2.4×

Dividends and buybacks

HTFLMRK
Dividends and buybacks
Dividend yield–2.3%
Dividend per share, 12 months–$3.40
Dividend growth a year, past–+5.8%over 5 years
Buyback yield–1.4%
Shareholder yield–3.7%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: HTFL or MRK

Didn't find what you were looking for?

Ask us
Which is bigger, Heartflow or Merck & Company?

By market value, Merck & Company ($366B) is about 88.0 times Heartflow ($4.2B), at today's prices.

How did HTFL and MRK stock do over the last 1 years?

Since November 14, 2025, HTFL's price moved +73.6% and MRK's +59.4%. With dividends: HTFL +73.6% (+73.6% a year), MRK +64.1% (+64.1% a year). Past returns do not predict future ones.

Which pays the higher dividend, HTFL or MRK?

The dividend yield at today's price is none for Heartflow and 2.29% for Merck & Company. Over the last twelve months they paid – and $3.40 per share.

Which has the higher profit margins, Heartflow or Merck & Company?

Over the last twelve months, the net margin was -33.1% for Heartflow and 3.6% for Merck & Company, and the operating margin -33.1% and –. Revenue was $239M and $67.4B.

Which is the better investment, Heartflow or Merck & Company?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.